Thursday, October 4, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall
Tracks: Adult ID, Epidemiology and Infection Control, Investigative ID, Pediatric ID
Presentations:
Use of Electronic Best Practice Alert (BPA) to Reduce Inappropriate Testing for Clostridium difficile infection (CDI) at a Tertiary Care Center
John P. Mills, MD;
Robert Chang, MD, FACP, SHFM;
Krishna Rao, MD, MS;
Chris Zimmerman, PharmD;
Hee-Won Yoon, MPH;
Carolyn Dombecki, MPH, CIC;
Laraine L. Washer, MD
Evaluation of a Pilot Initiative for Tracking and Monitoring Indications Associated with Antibiotic Orders
Jamie John, PharmD;
Nicole Harrington, PharmD, BCPS;
Julianne Gardner, PharmD;
Jillian Dougherty, PharmD, BCPS;
Donna Walsh, PharmD;
Erin Dzuriak, PharmD;
Marci Drees, MD, MS;
Stephen Eppes, MD;
Sharath Kharidi, MD;
Linda Cheung, PharmD Candidate
Successes of a system-directed and multi-faceted inpatient antimicrobial stewardship program in a large, integrated delivery organization
Peter Colley, PharmD, BCPS-AAHIVQ;
Rema Thyagarajan, PharmD, BCPS;
Hoa Nguyen, MD, MS, PhD;
Andrew Masica, MD, MSCI;
Donald Storey, MD
Title: Effective Antimicrobial StewaRdship StrategIES (ARIES): cluster-randomized trial of a clinical decision support system to supplement antibiotic prospective review and feedback
Shi Thong Heng, BSc (Pharm);
Joshua Wong, Master of Science (Statistics);
Barnaby Young, MSc, MB BChir, MRCP, DLSHTM;
Li Min Ling, MBBS;
Brenda Ang, MBBS, M Med, MPH, FAMS, FSHEA;
Tau Hong Lee, MBBS;
Angela Chow, MBBS, MMed, MS, PhD;
Min Yi Yap, Bsc Pharm;
Hui Lin Tay, Msc Clinical Pharmacy;
Sock Hoon Tan, Bachelor of Science (Pharmacy);
Christine Teng, MS;
David Lye, FRACP, FAMS, FRCP;
Tat Ming Ng, Doctor of Pharmacy (PharmD)
A Novel inpatient Antibiotic Stewardship Assistance Program (ASAP) using Real-Time Electronic Health Record Data, Prediction Modeling and Epidemiologic Data to Provide Personalized Empiric Antibiotic Recommendations
Nirav Shah, MD;
Mary Ellen Acree, MD;
Clayton Patros, PharmD, BCPS;
Mira Suseno, PharmD;
Jennifer Grant, MD;
Gary Fleming, BE;
Bryce Hadsell, BS;
Jeffery Semel, MD, FIDSA, FSHEA;
Courtney Hebert, MD, MS;
Kamaljit Singh, MD;
Lance Peterson, MD
Duration of Antimicrobial Therapy: The Impact of Defaults
Rebekah Wrenn, PharmD;
Tony Diez, Sr., MBA, RRT;
Nicholas Turner, MD;
Christina Sarubbi, PharmD;
Deverick J. Anderson, MD, MPH, FIDSA, FSHEA;
Rebekah W. Moehring, MD, MPH
Mandatory Antimicrobial Duration at the Time of Computerized Physician Order Entry: What’s the Harm?
Alaina Burns, PharmD;
Ann Wirtz, PharmD;
Gina Weddle, DNP, RN, CPNP;
Tammy Frank, RPh, CPHIMS;
Richard Ogden, PharmD, MBA, BCPS;
Brian O'Neal, PharmD, MS, FASHP;
Jennifer Goldman, MD, MS
CME Credits: Maximum of 0.00 hours of
AMA PRA Category 1 Credit™
